Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By boosting these https://jasontbzd925338.diowebhost.com/91266301/setmelanotide-a-promising-new-treatment-for-obesity